SEC reporting owner

Atlas Venture Associates XI, LLC SEC insider disclosures

Reporting owner CIK	0001780067
Issuers	8
Qualifying disclosures	46
Public purchases	8
Recent-window purchases	1
Recent-window sales	0
Last public filing	2025-02-11
Coverage	verified

Issuer relationships

Akero Therapeutics, Inc. (AKRO)
Dyne Therapeutics, Inc. (DYN)
Ikena Oncology, Inc. (IKNA)
Day One Biopharmaceuticals, Inc. (DAWN)
Xilio Therapeutics, Inc. (XLO)
Third Harmonic Bio, Inc. (THRD)
Korro Bio, Inc. (KRRO)
Sionna Therapeutics, Inc. (SION)

Recent SEC transactions

Publicly available	Trade date	Ticker	Code	Shares	Reported value
2025-02-10	2025-02-10	SION	P	60,000	Not reported

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.